Skip to main content

Table 2 Bivariate analysis of prognostic factors of patients with bacteremia acquired in intensive care units

From: Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis

Variables

Median survival time (days)

95 % CI

HR

95 % CI

Death/total (%)

P

Age > 60 years

 Yes

5

0.00–10.82

1.67

1.08–2.58

37/53 (70)

0.02

 No

20

11.07–28.93

1

 

47/88 (53)

Sex

 Male

9

4.32–13.69

1.49

0.95–2.35

56/87 (64)

0.08

 Female

25

9.67–40.34

1

 

28/54 (52)

APACHE II Score > 20

 Yes

10

3.48–16.52

1.11

0.72–1.70

39/60 (65)

0.64

 No

15

5.10–24.9

1

 

45/81 (56)

CHARLSON Score > 3

 Yes

15

1.78–28.22

1.18

0.76–1.84

31/48 (65)

0.46

 No

11

5.32–16.68

1

 

53/93 (57)

Co-morbid condition

 Diabetes mellitus

  Yes

7

a

1.67

1.03–2.70

23/31 (74)

0.03

  No

16

6.86–25.14

1

 

61/110 (55)

 Liver cirrhosis

  Yes

5

0.01–9.99

1.58

0.96–2.59

21/28 (75)

0.07

  No

16

4.30–27.70

1

 

63/113 (56)

 Cancer

  Yes

18

0.00–39.72

0.87

0.52–1.46

18/33 (55)

0.59

  No

10

5.01–14.99

1

 

66/108 (61)

 Solid organ transplant

  Yes

5

0.98–9.02

1.31

0.80–2.15

21/30 (70)

0.28

  No

16

7.22–24.78

1

 

63/111 (57)

 Hematopoietic stem cell transplant

  Yes

7

a

0.87

0.12–6.26

1/2 (50)

0.89

  No

11

4.21–17.79

1

 

83/139 (60)

 HIV infection

  Yes

a

a

0.61

0.22–1.66

4/9 (44)

0.33

  No

10

4.12–15.88

1

 

80/132 (61)

 Chronic renal disease

  Yes

10

0.56–19.45

1.30

0.79–2.14

21/31 (68)

0.29

  No

13

3.92–22.08

1

 

63/110 (57)

 Obstructive pulmonary disease

  Yes

8

0.00–21.58

1.73

0.92–3.26

11/12 (92)

0.09

  No

12

3.85–20.15

1

 

73/129 (57)

 Trauma

  Yes

a

a

0.57

0.25–1.30

6/15 (40)

0.18

  No

10

3.27–16.73

1

 

78/126 (62)

 Systemic arterial hypertension

  Yes

8

2.39–13.61

1.16

0.75–1.80

33/56 (59)

0.51

  No

15

6.39–23.61

1

 

51/85 (60)

ICU length of stay previous to bacteremia > 8 days

 Yes

20

8.90–31.10

0.78

0.51–1.21

37/65 (57)

0.27

 No

9

5.20–12.80

1

 

47/76 (62)

Initial site of infection

 Primary bloodstream

  Yes

13

4.71–21.29

1.01

0.63–1.62

60/101 (59)

0.97

  No

9

2.98–15.02

1

 

24/40 (60)

 Pneumonia

  Yes

8

0.67–15.33

1.32

0.68–2.56

10/14 (71)

0.41

  No

13

4.88–21.13

1

 

74/127 (58)

 Surgical site

  Yes

13

4.22–21.78

1.22

0.58–2.52

76/130 (58)

0.60

  No

9

3.53–14.47

1

 

8/11 (73)

 Urinary tract

  Yes

a

a

0.05

0.00–10.63

0/3 (0)

0.27

  No

a

a

1

 

84/138 (61)

 Skin and soft tissue

  Yes

1

a

1.40

0.34–5.71

2/3 (67)

0.64

  No

12

5.27–18.73

1

 

82/138 (59)

Acinetobacter spp.

 Yes

2

0.00–4,51

1.85

1.21–2.85

43/59 (73)

0.005

 No

24

19.42–28,58

1

 

41/82 (50)

IIAT

 Yes

9

4.46–13.54

1.53

0.98–2.36

50/73 (68)

0.057

 No

24

7.06–40.95

1

 

34/68 (50)

  1. CI Confidence interval, HR Hazard Ratio, ICU intensive care unit, IIAT initial inappropriate antimicrobial treatment
  2. aNot possible to calculate median time and confidence interval